TP53 and neoplasm: SIRT1 has been proposed to promote tumor development and progression, as SIRT1-mediated deacetylation suppresses the functions of several tumor suppressors, including p53, p73, and hypermethylated in cancer 1 (HIC1) [23,24,25].